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Mycobacterium tuberculosis causes tuberculosis (TB), a disease that killed more than
1.5 million people worldwide in 2014, and the Bacillus Calmette Guérin (BCG) vaccine is
the only currently available vaccine against TB. However, it does not protect adults.
Th1 and Th17 cells are crucial for TB control, as well as the neutrophils that are
directly involved in DC trafficking to the draining lymph nodes and the activation of
T lymphocytes during infection. Although several studies have shown the importance
of neutrophils during M. tuberculosis infection, none have shown its role in the
development of a specific response to a vaccine. The vaccine mc2-CMX was shown
to protect mice against M. tuberculosis challenge, mainly due to specific Th1 and Th17
cells. This study evaluated the importance of neutrophils in the generation of the Th1-
and Th17-specific responses elicited by this vaccine. The vaccine injection induced a
neutrophil rich lesion with a necrotic central area. The IL-17 KO mice did not generate
vaccine-specific Th1 cells. The vaccinated IL-22 KO mice exhibited Th1- and Th17-
specific responses. Neutrophil depletion during vaccination abrogated the induction
of Th1-specific responses and prohibited the bacterial load reduction observed in the
vaccinated animals. The results show, for the first time, the role of neutrophils in the
generation of specific Th1 and Th17 cells in response to a tuberculosis vaccine.
Keywords: tuberculosis vaccines, Th1/Th17 responses, neutrophils
INTRODUCTION
The only available prevention against tuberculosis (TB) is the Mycobacterium bovis BCG vaccine,
which is effective against the miliary and meningitis forms of TB in children; however, its efficacy
varies greatly among adults, and, as result, TB is the second leading cause of death by an infectious
agent worldwide (Kozak and Behr, 2011; World Health Organization [WHO], 2015). Classically,
Th1 cells (IFN-γ-, TNF-α-, and IL-12-producing T cells) play an important role in TB control
(Cooper and Khader, 2008). For many years, it was accepted that IFN-γ production by T cells
was the most important and effective response in the control of TB (Flynn and Chan, 2001).
Nevertheless, new studies have shown that, in addition to IFN-γ, the production of other types
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of cytokines is essential for the generation of an efficient
protective response (Gopal et al., 2013). Additionally, CD8+ T
cells, both in humans and animals, respond to M. tuberculosis
infection (Lin and Flynn, 2015) being of great importance during
the chronic stage of infection. Recently, Booty et al. (2016),
showed that IL-12 is crucial for CD8+ T cell priming as is
IFN-γ to maintain the effector and memory cell subsets during
M. tuberculosis infection.
For instance, some of the vaccines against TB that are
currently undergoing clinical trials have shown an important
role for the Th17 cells in the induction of protection (Desel
et al., 2011; Hwang et al., 2011). Th17 cells secrete IL-17, IL-22
and IL-21 (Fouser et al., 2008). IL-22, although early induced
during M. tuberculosis infection, is not crucial to induce Th1
cells, thus was not associated to protection (Behrends et al.,
2013). The role of IL-17 in protection against M. tuberculosis
infection may be related to its role in the induction of Th1
cells (Weaver and Murphy, 2007; Kolls and Khader, 2010). IL-
17 is known to activate and recruit neutrophils (Ye et al., 2001;
Happel et al., 2005). Additionally, Monin et al. (2015) showed
that this cytokine favors the recall of vaccine-specific memory T
cells in response to M. tuberculosis challenge through an IL-23-
dependent mechanism. Recently, it was showed that neutrophils
when activated by IL-23 also produce IL-17 and IL-22 (Chen
et al., 2016).
Neutrophils are indispensable for the first line of defense
against microorganisms (Ye et al., 2001; Torrado and Cooper,
2010), as they can activate different cell types, such as
macrophages, dendritic cells (DC), natural killer (NK) cells and
B lymphocytes, and secrete cytokines, such as IL-1β (Morel et al.,
2008; Cho et al., 2012). Furthermore, Blomgran and Ernst (2011)
demonstrated that lung neutrophils are directly involved in DC
trafficking to the draining lymph nodes and in the activation of T
lymphocytes in a mouse model of TB infection. Both CD4+ and
CD8+ T cells can be primed to M. tuberculosis antigens aided by
DC crosspriming of engulfing apoptotic bodies from neutrophils
(Behar, 2013).
Considering that neutrophils are important in the host–
pathogen interaction, and IL-17 and IL-22 are involved in both
innate and specific immune responses to M. tuberculosis, we
addressed the role of neutrophils in the induction of specific Th1
and Th17 cells in response to vaccination against TB and the
subsequent protective outcome. To investigate this, we used a
vaccine that is capable of inducing Th1- and Th17-specific T cell
responses and is protective against TB (Junqueira-Kipnis et al.,
2013).
MATERIALS AND METHODS
Vaccine and rCMX Preparation
The protocols to prepare the vaccine as previously
described (Junqueira-Kipnis et al., 2013), were strictly
followed. Briefly, the mc2-CMX vaccine was diluted to
1 × 108 CFU/mL in PBS with 0.05% Tween 80 (PBST).
rCMX was obtained as previously described (de Sousa et al.,
2012). After protein purification, lipopolysaccharide (LPS) was
removed using the ToxinEraserTM Endotoxin Removal Kit
(GenScript).
Animals
Eight-week-old C57BL/6, IL-22 gene knockout (KO) and IL-17ra
KO mice, all from C57BL/6 background (originally from Jackson
Laboratory) were donated by Dr. João Santana da Silva from
Universidade de São Paulo and were housed and bred in micro
isolators adapted to HEPA filtered racks with 12 h light/dark
cycles, temperature ranging from 20 to 24◦C, and 50% humidity
at the animal facilities of the Institute of Tropical Disease and
Public Health. The procedures used in this study were approved
by the Ethical Committee on animal use of Federal University
of Goiás [Comitê de Ética no Uso de Animais da Universidade
Federal de Goiás (Protocol number: 027/14)].
Vaccination Design
The C57BL/6 (n= 12), IL-17 KO (n= 12), and IL-22 KO (n= 12)
mice were subcutaneously vaccinated with 100 µL (107 CFU) of
mc2-CMX (M. smegmatis expressing CMX). The second dose was
administered 15 days later at the inflammatory spot generated
by the first immunization. The controls from each mouse strain
were vaccinated with PBST (n = 12). At 15 days after the last
vaccination, five animals from each group were euthanized by
cervical dislocation by a trained veterinarian, and the vaccine
skin lesions and spleens were collected. The remaining animals
were intravenously challenged with M. tuberculosis strain H37Rv
(105 CFU) 30 days after the booster vaccination.
M. tuberculosis Infection
Cultures of M. tuberculosis (H37Rv) in 7H9 containing 0.05%
Tween 80 and OADC were grown to mid-log phase, and aliquots
were frozen in 20% glycerol at −80◦C. The concentration of the
mycobacteria lot was determined 30 days later by plating and
counting the CFUs from representative frozen vials. On the day
of the challenge, aliquots were thawed, the concentration was
adjusted to 106 CFU/mL, and 100 µL were intravenously injected
into the lateral tail vein. One day after infection, one animal from
each group was euthanized, and the lungs were homogenized and
plated on 7H11 supplemented with OADC media to determine
the initial bacterial load. The average load of bacteria in the lungs
at day one was 3.4× 104 CFU.
M. tuberculosis Load Quantification
Thirty days after the challenge, the animals were euthanized and
the right cranial and medial lung lobes were homogenized to
verify the bacterial load as described above.
Specific CD4 T Immune Response to
CMX
The specific immune response induced by the vaccination
was tested before the challenge (15 days after the booster)
and 30 days after the M. tuberculosis infection. Six animals
from each group were euthanized by cervical dislocation and
the spleens were removed to assess the specific immune
responses. The single cell suspension obtained after passage
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through a 70 µm strainer (BD Biosciences) was treated with
lysis buffer (0.15 M NH4Cl and 10 mM KHCO3). After
washing with RPMI, the concentration of the suspension was
adjusted to 1 × 106/mL, and 200 µL were plated in 96-
well plates (Cell WellsTM). The cells were treated with ConA
(1 µg/mL), rCMX (10 µg/mL) or medium and cultured for
4 h at 37◦C in a CO2 incubator. Then, monensin (eBioscience,
3 µM) was added, and the cells were incubated for an
additional 4 h. The plates were centrifuged and the cells were
incubated with a FITC-conjugated anti-CD4 antibody (BD
PharMingen) for 30 min. Then, the cells were washed, fixed,
and permeabilized using the BD Cytofix/Cytoperm kit. The cells
were further incubated for 30 min with a PercP-conjugated anti-
IL-17 antibody (eBioscience) and an PE-conjugated anti-IFN-
γ antibody (eBioscience). The cell suspensions were acquired
using a BD Biosciences FACSVerseTM and analyzed with the
FlowJo 9.0 Software. A total of 100,000 events or at least 20,000
lymphocytes were acquired per sample. The specific immune
response to CMX was obtained by subtracting the percentage
of IFN-γ+ or IL-17+ non-stimulated cells from the percentage
of IFN-γ+ or IL-17+ cells stimulated with CMX. To calculate
the total number of CD4 T cells expressing IFN-γ or IL-17, the
above percentage differences were multiplied by the total number
of splenocytes obtained from each animal. The results were
presented as average and standard deviation of each treatment
group. Responsiveness of the cell suspensions was checked by
Con-A stimulation controls.
Neutrophil Evaluation
The neutrophils from the vaccinated animals were evaluated
30 days after the challenge with M. tuberculosis. The splenocytes
were obtained as described above. The cells were incubated for
30 min with APC-conjugated anti-GR1 (BD PharMingen), PercP-
conjugated anti-CD14, PE-conjugated anti-CD11c and FITC-
conjugated anti-CD11b antibodies (eBioscience). Then, the cells
were washed with PBS and fixed with paraformaldehyde using
Perm Fix (BD Cytofix). A total of 100,000 events were acquired
using BD Biosciences FACSVerseTM and analyzed with the
FlowJo 9.0 Software. The neutrophils percentage was determined
evaluating singlets that were GR-1+, CD11c−, and CD14−.
The total number of neutrophils was obtained multiplying the
percentage of neutrophils by the total number of splenocytes
from each animal.
Neutrophil Depletion
Three groups of C57BL/6 mice were treated with 200 µg of anti-
mouse Ly6G antibodies (BioXcell; clone 1A8), Rat IgG2a isotype
control (BioXcell; clone 2A3), or not treated (PBS control),
according to the protocol described (Kozakiewicz et al., 2013).
The animals in each of these groups (n = 12 mice per group)
were equally subdivided into two groups: one that was vaccinated
with mc2-CMX (107 CFU/animal) and a control PBST vaccinated
group. Therefore the experiments consisted of six groups (n= 6):
Ly6G depleted and vaccinated; Ly6G depleted not vaccinated;
isotype control treated and vaccinated; isotype control treated not
vaccinated; not treated and vaccinated (vaccine control); and the
group not treated nor vaccinated (PBS control). The depletion
started 1 day before the vaccination scheme and was maintained
for 31 days. At the end of the treatment, three animals from
each experimental group were euthanized, and the lungs and
spleens were collected and evaluated by flow cytometry. The
spleen cells were obtained as described above, and the lung cells
were obtained as described (Junqueira-Kipnis et al., 2013). The
remaining animals (n = 3 for each experimental group) were
infected with M. tuberculosis (105 CFU/mouse) 46 days after
the beginning of the treatment. Thirty days after the challenge,
the animals were euthanized, and the lungs were evaluated by
flow cytometry. The right cranial and medial lung lobes were
homogenized to verify the bacterial load as described above. The
experiment was repeated twice.
Tissue Damage Evaluation
The tissues from the vaccination site and the right caudal lung
lobes were collected and fixed in 10% paraformaldehyde. Five-
micrometer-thick fixed tissues were placed on slides, stained
with hematoxylin and eosin (H&E), and evaluated using an
optical microscope (Axioscope A1; Carl Zeiss). The slides
were evaluated by a certified Pathologist from Faculdade de
Odontologia-Universidade Federal de Goiás blinded to original
section sources. Scores were determined based on the area
with lesions relative to the area of the total visual field using
AxioVision microscopy Software. The results are presented as
the percentage of area with lesions. Three different fields were
evaluated per slide for each animal from each group (da Costa
et al., 2014).
Statistical Analysis
The data were imported to Excel (version 14.3.4, 2011) and
analyzed using Graphpad Software 4.0. The comparisons between
the groups were evaluated by ANOVA followed by the Mann–
Whitney U test. p < 0.05 was considered statistically significant.
For depletions assay the groups were using Tukey’s multiple
comparison test.
RESULTS
Subcutaneous Vaccination with
M. smegmatis mc2-CMX Induces Local
Abscess Formation
Considering that the first encounter with the antigen/pathogen
by the innate cells will dictate the type and magnitude of the
specific immune response, we questioned whether neutrophils
were involved in the lesions induced by the vaccination with
mc2-CMX. To determine this, the subcutaneous lesion at the site
of vaccine injection from the C57BL/6 mice was collected and
evaluated 15 days after the immunization. Figure 1 shows that the
vaccine induces abscess formation (Figures 1A,B). The abscess
was primarily composed of a central necrosis surrounded by
neutrophils and fibroblasts (Figure 1B). The neutrophilic content
of the lesion induced by the mc2-CMX vaccination suggested
that those cells might be important in generating a protective
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FIGURE 1 | Vaccination induces abscess at the injection site. The C57BL/6, IL-17 KO, and IL-22 KO mice were subcutaneously injected with the
Mycobacterium smegmatis-CMX (mc2-CMX) vaccine, and the skin lesion at the vaccination site was evaluated by H&E staining 15 days after immunization. The
mc2-CMX vaccine induces abscess with higher influx of neutrophils (arrow heads) and central necrosis (arrow) in the C57BL/6 (A,B), IL-22 KO (C,D), and IL-17 KO
mice (E,F). Lesions were blindly scored based on the area with lesions relative to the area of the total visual field. The results are presented as the mean percentage
of area with lesions from three mice per group (G). This is one representative result from three different experiments. 100× (A,C,E) and 400× (B,D,F) magnifications.
∗p < 0.05.
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FIGURE 2 | The IL-17 KO mice do not generate an adequate Th1 anti-CMX specific response after vaccination. Mice were vaccinated with mc2-CMX or
with PBST and their splenocytes were in vitro re-stimulated with CMX or not. Th1 cells, defined as CD4+ IFN-γ+ T cells were determined after gate analysis using
isotype control as reference (A). The total numbers of cells CD4+ IFN-γ+ T splenocytes were determined (B). The results shown represent the mean and standard
deviation from a representative experiment. ∗p < 0.05.
Frontiers in Microbiology | www.frontiersin.org 5 June 2016 | Volume 7 | Article 898
fmicb-07-00898 June 9, 2016 Time: 17:5 # 6
Trentini et al. Th17 and Neutrophils in Tuberculosis Vaccination
response, which involves specific Th1 and Th17 cells (Junqueira-
Kipnis et al., 2013). To address if IL-17 played a role in the
recruitment of neutrophils, we used IL-17 KO mice.
IL-17 KO (IL-17ra−/−) mice were immunized with mc2-CMX
and the vaccine lesions were evaluated to assess the role of IL-17
in the innate/adaptive immune response to the live vaccine. The
lesions from the IL-17 KO mice were smaller when compared to
the lesions from the C57BL/6 mice (observe Figures 1A,C). The
scoring of the lesion from each mouse evidenced this difference
(Figure 1G). Because IL-22 has been associated with Th17
induction (Liang et al., 2006) and local inflammation (as well as
a synergistic action with IL-17 to induce neutrophil activation;
Fouser et al., 2008; Sonnenberg et al., 2010), IL-22 KO mice were
also vaccinated. Unexpectedly, the lesions in these mice occupied
larger areas than the lesions generated in the IL-17 KO mice
(Figures 1E–G). Regardless of the mouse genetic background, the
lesion induced at the site of vaccination was neutrophilic with an
area of central necrosis.
The Absence of IL-17 Abolishes the
Induction of Specific CD4+IFN-γ+ T Cells
in the Spleens of Vaccinated Animals
The cytokines and cells that are activated at the site of the
infection/vaccination could define the type of specific immune
response induced. Therefore, we addressed the question of
whether the protective immune response induced by mc2-
CMX could be maintained in the absence of IL-17 or IL-
22. Thus, the response was evaluated in the IL-17 KO and
IL-22 KO mice vaccinated with mc2-CMX. Fifteen days after
immunization, the induced CMX specific gamma interferon-
positive CD4 (CD4+IFN-γ+) T cells were evaluated (Figure 2A).
While the IL-17 KO mice did not show an increase in the specific
CD4+IFN-γ+ T cells in the spleens of vaccinated animals, the IL-
22 KO mice exhibited levels similar to the C57BL/6 vaccinated
mice (Figure 2B). These results suggest that the Th1- CMX
specific response to the vaccine was not adequately generated in
the absence of IL-17.
Vaccination in the Absence of IL-17
Abrogates the Th1-Specific Response
and the Protection Induced by mc2-CMX
Vaccine after M. tuberculosis Challenge
To evaluate if IL-17 and IL-22 were involved in the recall of
the immune response generated by the mc2-CMX vaccine after
M. tuberculosis challenge, the wild type, IL-17 KO and IL-22 KO
mice were vaccinated with mc2-CMX and were infected with
M. tuberculosis 30 days later. As shown in Figure 3, C57BL/6
and IL-22 KO mice vaccinated with mc2-CMX exhibited higher
total cell number (Figure 3) levels of CMX specific CD4+IFN-
γ+ T cells compared to the animals that were only infected with
M. tuberculosis. Whereas the IL-17 KO mice that were vaccinated
and challenged with M. tuberculosis presented CD4+IFN-γ+
response levels similar to that observed with infection of IL-
17 unvaccinated mice, which in turn presented response levels
similar to the other genetic background mice (compare diamond
filled bars of Figure 3).
FIGURE 3 | Absence of Th1 anti-CMX specific recall response among
IL-17 KO mice vaccinated and challenged with M. tuberculosis. Mice
vaccinated with mc2-CMX or with PBST were infected with M. tuberculosis
and 30 days later their splenocytes were in vitro re-stimulated with CMX or
not. Th1 cells, defined as CD4+ IFN-γ+ T cells were determined after gate
analysis using isotype control as reference. The total numbers of cells
CD4+ IFN-γ+ T splenocytes were determined. The results shown represent
the mean and standard deviation from a representative experiment. ∗p < 0.05.
Neutrophils are also important in M. tuberculosis elimination;
therefore, we addressed whether the significant influx of Th1
and Th17 cells at 30 days post infection could affect the
splenic neutrophil numbers and if vaccination with mc2-CMX
could modulate this cell population (representative dot plots are
shown in Figure 4A). Although infection triples the number of
neutrophils in the unvaccinated mice, the mc2-CMX-vaccinated
animals exhibited neutrophils levels that were similar to those of
the non-infected mice (Figure 4B). Interestingly, vaccination of
the IL-22 KO mice did not modulate the number of neutrophils.
As expected, due to the lower neutrophil levels exhibited by
IL-17 KO mice prior to vaccination, neither vaccination nor
M. tuberculosis infection increased the number of neutrophils
(Figure 4B).
Because the specific responses induced by the vaccination
exhibited different outcomes in the mice with different genetic
backgrounds, we decided to verify whether the absence of
IL-17 or IL-22 interfered with the lesions and protection
induced by the mc2-CMX vaccine. The vaccination of all mouse
strains prevented the lung inflammatory reactions induced by
M. tuberculosis infection (Figure 5J); nonetheless, the vaccinated
C57BL/6 and IL-22 KO mice exhibited fewer parenchyma
alterations compared to the IL-17 KO mice (Figure 5).
The inflammatory lesions of C57BL/6 infected animals were
composed by mononuclear cells mainly macrophages and
lymphocytes, with some neutrophils diffused throughout the lung
parenchyma (Figure 5C) while the vaccinated and infected mice
presented fewer lesions that were more organized and composed
mainly by macrophages and lymphocytes (Figure 5B, data
not shown). Infected IL-17 KO mice regardless of vaccination
status, by other hand, presented diffused inflammatory lesions
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FIGURE 4 | In the absence of IL-22, neutrophils from the spleens of the vaccinated mice are not modulated in the same manner as in wild type mice.
The C67BL/6, IL-17 KO, and IL-22 KO mice were vaccinated with mc2-CMX or PBST and challenged 30 days later with M. tuberculosis. (A) Representative dot plots
showing the neutrophil gating among the different study groups. (B) The mean and standard deviation of the total number of neutrophils is presented. The statistical
analysis shows comparison between uninfected groups (open bars), vaccinated and Mtb infected groups (diamond bars), and Mtb infected (solid bars). ∗p < 0.05.
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FIGURE 5 | Inflammatory response to M. tuberculosis infection in the lungs of the vaccinated C67BL/6, IL-17 KO, and IL-22 KO mice. The regular
architecture of the lungs from naïve mice (A,D,G) is profoundly altered by the inflammatory response induced by M. tuberculosis infection (C,F,I). Infection-induced
inflammation was reduced when the mice had been previously vaccinated with mc2-CMX (B,E,H), although the IL-17 KO mice showed a more discrete reduction
(E) than the C57BL/6 and IL-22 KO mice (B,F). The lesions of three different lung areas from each animal was scored and calculated as percentage area with lesion
(J). Note the absence of lesion reduction [as compared to non-vaccinated and infected animals (circles) and only infected (squares)] in the IL-17 KO group. The
mycobacterial load was determined and compared to the non-vaccinated animals (PBST + Mtb, squares). (K) While the vaccinated C57BL/6 and IL-22 KO mice
exhibited approximately one log reduction in the bacterial load compared to the non-vaccinated mice, the vaccinated IL-17 KO mice could not reduce the expected
bacterial load. The mean and standard deviation from six mice per group is presented. ∗p < 0.05.
also composed mainly by macrophages and lymphocytes
(Figures 5E,F, data not show). The infection of IL-22 KO
mice induced huge congestive inflammatory lesions also mainly
composed by mononuclear infiltrates and neutrophils (Figure 5I,
data not show) that were reduced at a lesser extent with mc2-
CMX vaccination (Figure 5H).
The lung bacterial load in mice challenged with
M. tuberculosis, 30 days after infection, was analyzed. In
the absence of IL-17, the mc2-CMX vaccine-induced protection
was abolished. However, in the absence of IL-22, the vaccine-
induced protection was similar to the protection induced in the
vaccinated and challenged C57BL/6 mice (Figure 5K). Together,
the results strengthen the importance of IL-17 in generating a
Th1-specific vaccine response after infection. Additionally, in
the absence of specific Th1 and Th17 cells (IL-17 KO mice), the
vaccine-induced protection was abolished.
Neutrophils Assist in the Induction of
Th1- and Th17-Specific Responses to
the mc2-CMX Vaccine
The local histological lesions induced by mc2-CMX vaccination
and the absence of a specific Th1 response in the vaccinated
IL-17 KO mice and the absence of neutrophil modulation in
the vaccinated and challenged IL-22 KO mice compelled us to
raise the question of whether neutrophils were important for
the generation of a protective immune response. This question
was addressed by treating the wild type mice with an anti-
Ly6G antibody or isotype control prior to vaccination and for
21 days after immunization. Neutrophil depletion (Figures 6A,B)
provoked a significant reduction in the total numbers of CMX
specific Th1 (Figures 7A,C) and Th17 (Figures 7B,D) cells in
the lungs and spleen. After M. tuberculosis infection, the animals
whose neutrophils (Ly6G+) were depleted during vaccination
exhibited similar bacterial load compared to that of the non-
depleted and non-vaccinated animals (Figure 8A).
Neutrophil Depletion during Vaccination
Does Not Interfere with the Immune
Response Induced by the Infection with
M. tuberculosis
In addition to being responsible for the generation of the
vaccine CMX specific immune response, neutrophils could
have affected the ability of the C57BL/6 mice to respond to
M. tuberculosis. As shown in Figure 8, depletion of neutrophils
did not influence the Th1 or Th17 specific cell response
(diamonds filled bars, α-Ly6G group infected withM. tuberculosis
compared with PBS or isotype control treated infected mice).
Therefore, early depletion of neutrophils did not interfere with
the ability of M. tuberculosis infection to induce a Th1 and Th17
response.
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FIGURE 6 | Neutrophil depletion. (A) Representative dot plots showing lung neutrophil depletion efficiency. (B) The total number of neutrophils in the spleen was
calculated and the efficiency of the depletion is shown. The mean and standard deviation from five mice per group is presented. ∗p < 0.05.
On the other hand, the absence of Th1 or Th17
CMX specific recall responses in the lungs of mice that
were depleted of neutrophils during vaccination, seen as
an increase of the response of vaccinated and infected
mice (closed bars) compared to non-vaccinated and
infected mice (diamond filled bars), suggest that it may be
responsible for the loss of protection induced by the vaccine
(Figure 8).
DISCUSSION
This work shows, for the first time, that neutrophils are required
for the Th1- and Th17- specific responses generated by a TB
vaccine. Additionally, it shows evidence that the IL-17 KO mice
vaccinated with mc2-CMX have a reduced ability to generate
Th1-specific responses and recall these cells after M. tuberculosis
challenge.
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FIGURE 7 | Neutrophil depletion abrogates the Th1 and Th17 cell induction in the lungs and spleen in response to the mc2-CMX vaccination. C57BL/6
mice treated with anti-Ly6G antibodies (anti-Ly6G) to deplete the neutrophils or with isotype control (isotype control) or with PBS (PBS) were vaccinated with
mc2-CMX (closed bars) or not vaccinated (PBST, open bars). The increase in the number of Th1 (A,C) and Th17 cells (B,D) induced by vaccination observed among
non-depleted mice (PBST and isotype control) was abrogated in the neutrophil-depleted group. ∗p < 0.05.
Vaccination with mc2-CMX induces increased levels of Th1
and Th17 spleen cells. However, protection against tuberculosis
is only achieved when Th1 and Th17 cells that are specific
to Ag85, MPT-51, HspX or other M. tuberculosis proteins are
generated (Sonnenberg et al., 2010; da Costa et al., 2014; Monin
et al., 2015). Here, we show that mc2-CMX, a recombinant live
vaccine vector, induces neutrophilic abscess at the inoculation
site that is resolved 30 days after vaccination (Figure 1, data not
shown). There are lines of evidence indicating that IL-17 and IL-
22 induce inflammation and neutrophil migration (Sonnenberg
et al., 2010). In this study, the vaccine-induced lesions may reflect
a reduction of this function in the absence of IL-17. However, the
abscess observed in the IL-22 KO mice did not corroborate this
idea, as it was larger than the observed in the wild type mice. IL-22
has been associated with tissue remodeling and as a regulator of
the inflammatory reaction (Fouser et al., 2008; Chen et al., 2016),
thus the absence of IL-22 could explain the larger lesion observed
after mc2-CMX vaccination.
Using IL-22 KO mice infected with M. tuberculosis, Behrends
et al. (2013) showed that this cytokine was not crucial to the
control of the infection or the modulation of the specific immune
response induced by the infection. However, in humans, IL-
22 is directly involved in the specific response to tuberculosis
(Scriba et al., 2008). CD4 T cells and granulocytes produce IL-22;
however, the effector CD4 T cells from TB patients only increase
IL-22 production when stimulated with M. tuberculosis proteins
in vitro (Scriba et al., 2008; Cowan et al., 2012). It is not known
whether the IL-22 KO mice exhibit innate and adaptive immune
responses to the avirulent M. smegmatis, which differ from the
response to M. tuberculosis. It is important to note that, although
they exhibited larger lesion (i.e., abscess), the IL-22 KO mice were
able to clear these lesions in less than 1 month (Figure 1, data
not shown). Here we showed that in the absence of IL-22, the
specific Th1 or Th17 responses to mc2-CMX vaccination was
similar to the response observed among wild type vaccinated
mice. Thus, our results add to the knowledge that IL-22 is not
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FIGURE 8 | The absence of neutrophils during mc2-CMX vaccination
C57BL/6 mice abrogates protection and result in the absence of a Th1
and Th17 recall response. The C57BL/6 mice were treated with anti-Ly6G
to deplete neutrophils or treated with isotype control. Thirty days after
M. tuberculosis challenge the lung CFU were determined. The vaccine
protection efficiency was verified by comparing unvaccinated group
(PBST + Mtb, open squares) to vaccinated and challenged with
M. tuberculosis (mc2-CMX + Mtb, dotted squares) group (A). Three groups of
C57BL/6 mice were treated with anti-Ly6G antibodies (α-Ly6G) to deplete the
neutrophils, or with isotype antibodies (isotype control) or with PBS (PBS).
Within each group a subset was used as naïve uninfected control (PBST,
open bars), another as unvaccinated and M. tuberculosis challenged animals
(PBST + Mtb, diamond filed bars) and another groups was vaccinated with
mc2-CMX and challenged 30 days later with M. tuberculosis
(mc2-CMX + Mtb, solid bars). Neutrophil depleted mice were able to generate
a Th1 (B) and Th17 (C) response after M. tuberculosis infection (compare
diamond filled bars in the different treatment groups). Mice whose neutrophils
were depleted during vaccination, when challenged did not show an increase
in the Th1 and Th17 response seen among neutrophils sufficient groups
(compare diamond filled bars with closed filled bars within each treatment
group) ∗p < 0.05.
crucial for protection as well also to the induction of a protective
vaccine against tuberculosis. Nonetheless, the number of splenic
neutrophils was not modulated after M. tuberculosis infection as
observed for C57BL/6 vaccinated mice. This result may indicate
that this cytokine is anyhow important for the modulation of
the neutrophilic response to M. tuberculosis infection and further
studies should be done in order to address this fact.
Although controversial, our results show a direct correlation
between the induction of Th1-specific responses and the presence
of IL-17 in a mouse model of tuberculosis. Our results
corroborate those of Khader and Cooper (2008) who suggested
that the Th1 and Th17 cells are cross-modulated during infection,
and, in the absence of Th17, the protection and the Th1 response
induced by a subcutaneous M. tuberculosis vaccine (subunit
vaccine) were reduced (Khader et al., 2007). Additionally,
Umemura et al. (2007) showed that IFN-γ production was
reduced following a BCG infection (intratracheal infection) in
the absence of Th17 cells. In accordance with our results, these
findings imply that both Th1 and Th17 cells were important to
induce protection in response to a vaccine against M. tuberculosis.
In contrast, using a mucosal route of vaccination (subunit
vaccine), Gopal et al. (2013) showed that only the Th17-specific
cells were crucial to generate protection against M. tuberculosis
because the vaccinated IFN-γ KO mice showed some level of
protection that was abolished after IL-17 depletion. This scenario
suggests that the vaccine type and its components may be
important for defining the specific immune response induced by
a vaccine, as both authors used ESAT-6 as subunit vaccine against
M. tuberculosis but used different routes of vaccination and
different adjuvants. Our results and those of others confirmed
that subcutaneous vaccination induces both Th1- and Th17-
specific responses that are important for the protection of the
mice against M. tuberculosis and that the presence of IL-17 is
important for the induction of Th1 responses.
In this study, it is clear the role of specific Th1 and Th17 cells in
the protection induced by mc2-CMX vaccine, however, it was not
addressed if neutrophil depletion alters the CD8 T lymphocytes
activation or mycobactericidal function, fact that could have
contributed to the loss of the protection (Behar, 2013; Lin and
Flynn, 2015). In this sense neutrophils could be important for
DC crosspriming for M. tuberculosis antigens that would help its
mycobactericidal function during the post vaccinal challenge.
Several studies have shown that the protective immune
response to bacterial pathogens involves a Th17-specific
response. For instance, the protection induced by vaccines
for Bordetella pertussis (PW vaccine), Streptococcus pneumonia
(WCV vaccine), and Staphylococcus aureus (TSST-1 vaccine)
was reduced when the animals were treated with anti-IL-17
antibodies or when IL-17ra KO or IL-17 KO mice were used (Lu
et al., 2008; Ross et al., 2013; Narita et al., 2015).
Several mechanisms might be involved in the generation
of the Th1- and Th17-specific immune responses by some
M. tuberculosis vaccines. In this study, we show, for the first
time, a direct role for neutrophils. The antimicrobial functions
of neutrophils are very well known, and their deficiency
causes severe bacterial and fungal infections (Mantovani et al.,
2011). For example, in tuberculosis, neutrophils form neutrophil
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extracellular traps (NETs) that have been associated with
macrophage activation (Braian et al., 2013), and neutrophils
elastases are important in the control of mycobacterial growth
(Steinwede et al., 2012). In addition to this innate immune
response, neutrophils also assist in NK, B, and DC cell
activation (Jaeger et al., 2012; Schuster et al., 2013). Here,
we hypothesized that because neutrophils are clearly involved
in the response to this live vaccine and the reduction or
absence of neutrophils reduces both the Th1- and Th17-
CMX specific recall responses, they might be responsible
for activating DCs to induce both cells. This hypothesis is
corroborated by the fact that the DCs that ingest infected
neutrophils are better activated than the DCs that acquire
mycobacterial antigens in the absence of neutrophils (Nakae
et al., 2002). Rather, someone may argue that IL-17 KO mice
are not more susceptible to M. tuberculosis infection, although
showed a reduced neutrophilic response after the challenge when
compared to the wild type mice, and therefore neutrophils are
not important. Contrary to this observation, the results presented
here show the importance of these cells for the generation of
specific Th1 and Th17 cells induced by a live vector vaccine
against TB and do not intend to show its importance on the
infection.
The vaccine design used in this study has been shown
previously to generate specific Th1 and Th17 responses (against
CMX) that culminated with better protection than BCG against
an intravenous M. tuberculosis challenge (Junqueira-Kipnis
et al., 2013). Our results and those of others confirmed that
subcutaneous vaccination induces both Th1- and Th17-specific
responses that are important for the protection of the mice
against M. tuberculosis (Gopal et al., 2013). Here we show that
the presence of IL-17 and neutrophils are important for the
induction of a CMX Th1-specific response. Someone may reason
that intravenous M. tuberculosis infection may not be the natural
route of infection, as tuberculosis is primarily a pulmonary
disease, nonetheless these results are in agreement with the
literature including those studies that use aerosol mouse model
of infection. Though, it will be interesting in the future to address
if the neutrophils are also needed for other vaccines as well as
using different routes of infection.
CONCLUSION
This work shows for the first time that neutrophils are important
for the specific induction of Th1 and Th17 cells in response to a
live vaccine against M. tuberculosis.
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